Elite Pharmaceuticals Inc  

(Public, OTCMKTS:ELTP)   Watch this stock  
Find more results for OTC:ELTP
+0.008 (3.84%)
After Hours: 0.200 -0.008 (-3.70%)
Jul 2, 4:13PM EDT  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.20 - 0.21
52 week 0.17 - 0.43
Open 0.20
Vol / Avg. 390,239.00/1.14M
Mkt cap 128.63M
P/E 5.11
Div/yield     -
EPS 0.04
Shares 631.06M
Beta -0.05
Inst. own 0%
Jun 16, 2015
Full Year 2015 Elite Pharmaceuticals Inc Earnings Call
Jun 15, 2015
Full Year 2015 Elite Pharmaceuticals Inc Earnings Release

Key stats and ratios

Q1 (Mar '15) 2015
Net profit margin -734.46% 576.83%
Operating margin -442.13% -329.14%
EBITD margin - -316.83%
Return on average assets -140.87% 115.17%
Return on average equity - -
Employees 36 -
CDP Score - -


165 Ludlow Ave
NORTHVALE, NJ 07647-2305
United States - Map
+1-201-7502646 (Phone)
+1-302-6745266 (Fax)

Website links


Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology. Elite owns, licenses or contract manufactures eight products which are being sold commercially. These products are Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules, Hydromorphone Hydrochloride 8 milligram tablets, Phendimetrazine tartrate 35 milligram tablets, Phentermine 15 milligram capsules, Phentermine 30 milligram capsules and Naltrexone HCl 50milligram tablets. The Company focuses on the development of various types of drug products, including branded drug products which require new drug applications. The Company offers both, branded and generic products in various therapeutic categories.

Officers and directors

Jerry I Treppel Chairman of the Board
Age: 60
Nasrat Hakim President, Chief Executive Officer, Director
Age: 53
Carter J. Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 50
Ashok G. Nigalaye Ph.D. Chief Scientific Officer, Director
Age: 62
Jeenarine Narine Director
Age: 64
Barry H. Dash Ph.D. Independent Director
Age: 83
Jeffrey A. Whitnell Independent Director
Age: 58